Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics—2021 update. Circulation. 2021;143(8):e254–743.
Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38(6):1092–104.
Article CAS PubMed PubMed Central Google Scholar
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High-density lipoprotein as a protective factor against coronary heart-disease - Framingham study. Am J Med. 1977;62(5):707–14.
Article CAS PubMed Google Scholar
Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med. 1979;90(1):85–91.
Article CAS PubMed Google Scholar
Asztalos BF, Schaefer EJ. HDL in atherosclerosis: actor or bystander? Atheroscler Suppl. 2003;4(1):21–9.
Article CAS PubMed Google Scholar
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–35.
Article CAS PubMed Google Scholar
Greaves DR, Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res. 2009;50 Suppl(Supplement):S282–6.
Binder CJ, Papac-Milicevic N, Witztum JL. Innate sensing of oxidation-specific epitopes in health and disease. Nat Rev Immunol. 2016;16(8):485–97.
Article CAS PubMed PubMed Central Google Scholar
Yu H, Ha T, Liu L, Wang X, Gao M, Kelley J, et al. Scavenger receptor a (SR-A) is required for LPS-induced TLR4 mediated NF-kappaB activation in macrophages. Biochim Biophys Acta. 2012;1823(7):1192–8.
Article CAS PubMed PubMed Central Google Scholar
Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol. 1992;140(2):301–16.
CAS PubMed PubMed Central Google Scholar
Kruth HS. Sequestration of aggregated low-density lipoproteins by macrophages. Curr Opin Lipidol. 2002;13(5):483–8.
Article CAS PubMed Google Scholar
Martinet W, Schrijvers DM, De Meyer GR. Necrotic cell death in atherosclerosis. Basic Res Cardiol. 2011;106(5):749–60.
Article CAS PubMed Google Scholar
Kasikara C, Doran AC, Cai B, Tabas I. The role of non-resolving inflammation in atherosclerosis. J Clin Invest. 2018;128(7):2713–23.
Article PubMed PubMed Central Google Scholar
Opoku E, Traughber CA, Zhang D, Iacano AJ, Khan M, Han J, et al. Gasdermin D mediates inflammation-induced defects in reverse cholesterol transport and promotes atherosclerosis. Front Cell Dev Biol. 2021;9:715211.
Article PubMed PubMed Central Google Scholar
Wu XW, Molinaro C, Johnson N, Casiano CA. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens - implications for systemic autoimmunity. Arthritis Rheum. 2001;44(11):2642–52.
Article CAS PubMed Google Scholar
Murao A, Aziz M, Wang H, Brenner M, Wang P. Release mechanisms of major DAMPs. Apoptosis. 2021;26(3–4):152–62.
Article CAS PubMed PubMed Central Google Scholar
Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol. 2003;4(4):350–4.
Article CAS PubMed Google Scholar
Gardner JM, Fletcher AL, Anderson MS, Turley SJ. AIRE in the thymus and beyond. Curr Opin Immunol. 2009;21(6):582–9.
Article CAS PubMed PubMed Central Google Scholar
Takaba H, Takayanagi H. The mechanisms of T cell selection in the Thymus. Trends Immunol. 2017;38(11):805–16.
Article CAS PubMed Google Scholar
Emeson EE, Robertson ALJ. T lymphocytes in aortic and coronary Intimas. Their potential role in Atherogenesis. Am J Pathol. 1988;130(2):369–76.
CAS PubMed PubMed Central Google Scholar
Shimokama T, Haraoka S, Watanabe T. Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima. Modern Pathol. 1991;4(1):101–7.
Paulsson G, Zhou X, Tornquist E, Hansson GK. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2000;20(1):10–7.
Article CAS PubMed Google Scholar
Hermansson A, Ketelhuth DF, Strodthoff D, Wurm M, Hansson EM, Nicoletti A, et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med. 2010;207(5):1081–93.
Article CAS PubMed PubMed Central Google Scholar
Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1997;94(9):4642–6.
Article CAS PubMed PubMed Central Google Scholar
Daugherty A, Pure E, Delfel-Butteiger D, Chen S, Leferovich J, Roselaar SE, et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E−/− mice. J Clin Invest. 1997;100(6):1575–80.
Article CAS PubMed PubMed Central Google Scholar
Diaz A, Gonzalez-Alayon I, Perez-Torrado V, Suarez-Martins M. CD40-CD154: a perspective from type 2 immunity. Semin Immunol. 2021;53:101528.
Article CAS PubMed Google Scholar
Daub S, Lutgens E, Munzel T, Daiber A. CD40/CD40L and related signaling pathways in cardiovascular health and disease-the pros and cons for Cardioprotection. Int J Mol Sci. 2020;21(22):8533.
Article CAS PubMed PubMed Central Google Scholar
Bosmans LA, Bosch L, Kusters PJH, Lutgens E, Seijkens TTP. The CD40-CD40L dyad as immunotherapeutic target in cardiovascular disease. J Cardiovasc Transl Res. 2021;14(1):13–22.
Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A, et al. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation. 2013;127(9):1028–39.
Article CAS PubMed Google Scholar
Cochain C, Koch M, Chaudhari SM, Busch M, Pelisek J, Boon L, et al. CD8+ T cells regulate Monopoiesis and circulating Ly6C-high monocyte levels in atherosclerosis in mice. Circ Res. 2015;117(3):244–53.
Article CAS PubMed Google Scholar
Winkels H, Ehinger E, Vassallo M, Buscher K, Dinh HQ, Kobiyama K, et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass Cytometry. Circ Res. 2018;122(12):1675–88.
Article CAS PubMed PubMed Central Google Scholar
Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, et al. Single-cell immune landscape of human atherosclerotic plaques. Nat Med. 2019;25(10):1576–88.
Article CAS PubMed PubMed Central Google Scholar
Liuzzo G, Vallejo AN, Kopecky SL, Frye RL, Holmes DR, Goronzy JJ, et al. Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation. 2001;103(11):1509–14.
Article CAS PubMed Google Scholar
Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983;158(3):670–89.
Article CAS PubMed Google Scholar
Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest. 1997;99(11):2752–61.
Article CAS PubMed PubMed Central Google Scholar
Whitman SC, Ravisankar P, Elam H, Daugherty A. Exogenous interferon-γ enhances atherosclerosis in Apolipoprotein E−/− mice. Am J Pathol. 2000;157(6):1819–24.
留言 (0)